Portal:RareDisease/FeaturedPathways
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | == Rare diseases in general == | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP3584|250px||MECP2 and Associated Rett Syndrome (Homo sapiens)}} | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP3584|250px||MECP2 and Associated Rett Syndrome (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4312|250px||Rett syndrome causing genes}} | ||
|width=100px|{{#pwImage:Pathway:WP2447|250px||Amyotrophic lateral sclerosis (ALS) (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP2447|250px||Amyotrophic lateral sclerosis (ALS) (Homo sapiens)}} | ||
|width=100px|{{#pwImage:Pathway:WP3569|250px||Fanconi Anemia Pathway (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP3569|250px||Fanconi Anemia Pathway (Homo sapiens)}} | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |} |
| - | + | {| style="margin: 10px" | |
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4549|250px||Fragile X Syndrome}} |
| + | |width=100px|{{#pwImage:Pathway:WP4577|250px||WDR45 autophagy related pathway}} | ||
|width=100px|{{#pwImage:Pathway:WP4298|250px||Viral Acute Myocarditis (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP4298|250px||Viral Acute Myocarditis (Homo sapiens)}} | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4540|250px||Pathways Regulating Hippo Signaling}} |
| - | + | ||
|} | |} | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4541|250px||po-Merlin Signaling Dysregulation}} |
| - | |width=100px|{{#pwImage:Pathway: | + | |} |
| - | |width=100px|{{#pwImage:Pathway: | + | {| style="margin: 10px" |
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP3995|250px||Prion disease pathway}} |
| + | |width=100px|{{#pwImage:Pathway:WP4535|250px||Envelope proteins and their potential roles in EDMD physiopathology}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP2371|250px||Parkinsons Disease Pathway}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP2059|250px||Alzheimers Disease}} | ||
| + | |} | ||
| + | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP3853|250px||ERK Pathway in Huntington's Disease}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4656|250px||Joubert Syndrome}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4746|250px||Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism}} | ||
| + | |} | ||
| + | == Copy number variations == | ||
| + | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP4905|250px||1q21.1 copy number variation syndrome}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4906|250px||3q29 copy number variation syndrome}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4657|250px||22q11.2 Deletion Syndrome}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP3998|250px||Prader-Willi and Angelman Syndrome}} | ||
| + | |} | ||
| + | == Laminopathies == | ||
| + | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP4879|250px||Interacting Laminopathic Pathways}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4299|250px||Lamin A-processing pathway (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4320|250px||The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling}} | ||
|} | |} | ||
| + | == Inborn errors of metabolism == | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
|width=100px|{{#pwImage:Pathway:WP4507|250px||Molybdenum (Moco) cofactor biosynthesis}} | |width=100px|{{#pwImage:Pathway:WP4507|250px||Molybdenum (Moco) cofactor biosynthesis}} | ||
| Line 21: | Line 46: | ||
|width=100px|{{#pwImage:Pathway:WP4271|250px||Vitamin B12 Disorders}} | |width=100px|{{#pwImage:Pathway:WP4271|250px||Vitamin B12 Disorders}} | ||
|width=100px|{{#pwImage:Pathway:WP4297|250px||Thiamine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4297|250px||Thiamine Disorders}} | ||
| + | |} | ||
| + | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP4292|250px||Sulphur Amino Acids}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4259|250px||Disorders of Folate Metabolism and Transport}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4288|250px||MTHFR deficiency (additonal pathway)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4228|250px||Vitamine B6-Dependent and Responsive Disorders}} | ||
|} | |} | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| Line 30: | Line 61: | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
|width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4156|250px||Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism}} |
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4506|250px||Tyrosine Metabolism}} |
|width=100px|{{#pwImage:Pathway:WP4518|250px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}} | |width=100px|{{#pwImage:Pathway:WP4518|250px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}} | ||
|} | |} | ||
| Line 41: | Line 72: | ||
|} | |} | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4792|250px||Purine metabolism}} |
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4545|250px||Oxysterols derived from cholesterol}} |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
|} | |} | ||
| + | == Disorders of sex development == | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP4524|250px||The alternative pathway of fetal androgen synthesis}} | ||
|width=100px|{{#pwImage:Pathway:WP4673|250px||Genes involved in male infertility}} | |width=100px|{{#pwImage:Pathway:WP4673|250px||Genes involved in male infertility}} | ||
| - | |||
|width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}} | |width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}} | ||
|width=100px|{{#pwImage:Pathway:WP4871|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary}} | |width=100px|{{#pwImage:Pathway:WP4871|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary}} | ||
|} | |} | ||
| + | {| style="margin: 10px" | ||
| + | |width=100px|{{#pwImage:Pathway:WP4814|250px||Somatic Sex determination}} | ||
| + | |} | ||
| + | == CAKUT == | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
|width=100px|{{#pwImage:Pathway:WP4838|250px||Regucalcin in proximal tubule epithelial kidney cells}} | |width=100px|{{#pwImage:Pathway:WP4838|250px||Regucalcin in proximal tubule epithelial kidney cells}} | ||
|width=100px|{{#pwImage:Pathway:WP4835|250px||Peroxiredoxin 2 induced ovarian failure}} | |width=100px|{{#pwImage:Pathway:WP4835|250px||Peroxiredoxin 2 induced ovarian failure}} | ||
|width=100px|{{#pwImage:Pathway:WP4830|250px||GDNF/RET signalling axis}} | |width=100px|{{#pwImage:Pathway:WP4830|250px||GDNF/RET signalling axis}} | ||
| - | |||
| - | |||
| - | |||
|width=100px|{{#pwImage:Pathway:WP4818|250px||Conversion of Angiotensinogen to Angiotensin II}} | |width=100px|{{#pwImage:Pathway:WP4818|250px||Conversion of Angiotensinogen to Angiotensin II}} | ||
| - | |||
| - | |||
| - | |||
|} | |} | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4823|250px||Genes controlling renal nephrogenesis}} |
| - | + | ||
| - | + | ||
| - | + | ||
|} | |} | ||
| + | |||
List of featured pathways: | List of featured pathways: | ||
Revision as of 07:34, 7 May 2020
Contents |
Rare diseases in general
|
Image does not exist MECP2 and Associated Rett Syndrome (Homo sapiens) |
Image does not exist Rett syndrome causing genes |
Image does not exist Amyotrophic lateral sclerosis (ALS) (Homo sapiens) |
Image does not exist Fanconi Anemia Pathway (Homo sapiens) |
|
Image does not exist Fragile X Syndrome |
Image does not exist WDR45 autophagy related pathway |
Image does not exist Viral Acute Myocarditis (Homo sapiens) |
Image does not exist Pathways Regulating Hippo Signaling |
|
Image does not exist po-Merlin Signaling Dysregulation |
|
Image does not exist Prion disease pathway |
Image does not exist Envelope proteins and their potential roles in EDMD physiopathology |
Image does not exist Parkinsons Disease Pathway |
Image does not exist Alzheimers Disease |
|
Image does not exist ERK Pathway in Huntington's Disease |
Image does not exist Joubert Syndrome |
Image does not exist Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism |
Copy number variations
|
Image does not exist 1q21.1 copy number variation syndrome |
Image does not exist 3q29 copy number variation syndrome |
Image does not exist 22q11.2 Deletion Syndrome |
Image does not exist Prader-Willi and Angelman Syndrome |
Laminopathies
|
Image does not exist Interacting Laminopathic Pathways |
Image does not exist Lamin A-processing pathway (Homo sapiens) |
Image does not exist The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (Homo sapiens) |
Image does not exist The influence of laminopathies on Wnt signaling |
Inborn errors of metabolism
|
Image does not exist Molybdenum (Moco) cofactor biosynthesis |
Image does not exist Cysteine and Methionine catabolism |
Image does not exist Vitamin B12 Disorders |
Image does not exist Thiamine Disorders |
|
Image does not exist Sulphur Amino Acids |
Image does not exist Disorders of Folate Metabolism and Transport |
Image does not exist MTHFR deficiency (additonal pathway) |
Image does not exist Vitamine B6-Dependent and Responsive Disorders |
|
Image does not exist Disorders of the Krebs Cycle |
Image does not exist Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses |
Image does not exist Neurotransmitter Disorders |
Image does not exist Purine Disorders |
|
Image does not exist Pyrimidine Disorders |
Image does not exist Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism |
Image does not exist Tyrosine Metabolism |
Image does not exist Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases |
|
Image does not exist Cerebral Organic Acidurias |
Image does not exist Glycosylation and related congenital defects |
Image does not exist Metabolic pathway of LDL, HDL and TG |
Image does not exist Classical pathway of steroidogenesis, including diseases |
|
Image does not exist Purine metabolism |
Image does not exist Oxysterols derived from cholesterol |
Disorders of sex development
|
Image does not exist The alternative pathway of fetal androgen synthesis |
Image does not exist Genes involved in male infertility |
Image does not exist Mammalian disorder of sexual development |
Image does not exist Kisspeptin/Kisspeptin Receptor System in the Ovary |
|
Image does not exist Somatic Sex determination |
CAKUT
|
Image does not exist Regucalcin in proximal tubule epithelial kidney cells |
Image does not exist Peroxiredoxin 2 induced ovarian failure |
Image does not exist GDNF/RET signalling axis |
Image does not exist Conversion of Angiotensinogen to Angiotensin II |
|
Image does not exist Genes controlling renal nephrogenesis |
List of featured pathways:
- Pathway:WP3584 - MECP2 and Associated Rett Syndrome
- Pathway:WP2447 - Amyotrophic lateral sclerosis (ALS)
- Pathway:WP3569 - Fanconi Anemia Pathway
- Pathway:WP4320 - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
- Pathway:WP4299 - Lamin A-processing pathway
- Pathway:WP4298 - Viral Acute Myocarditis
- Pathway:WP4156 - Disorders of Phenylalanine and Tetrahydrobiopterin
- Pathway:WP4506 - Tyrosine Metabolism
- Pathway:WP4292 - Sulphur Amino Acids
- Pathway:WP4259 - Disorders of Folate Metabolism and Transport
- Pathway:WP4288 - MTHFR deficiency
- Pathway:WP4228 - Vitamine B6-Dependent and Responsive Disorders
- Pathway:WP4507 - Molybdenum (Moco) cofactor biosynthesis
- Pathway:WP4504 - Cysteine and Methionine catabolism
- Pathway:WP4271 - Vitamin B12 Disorders
- Pathway:WP4297 - Thiamine Disorders
- Pathway:WP4236 - Disorders of the Krebs Cycle
- Pathway:WP4153 - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
- Pathway:WP4220 - Neurotransmitter Disorders
- Pathway:WP4224 - Purine Disorders
- Pathway:WP4225 - Pyrimidine Disorder
- Pathway:WP4540 - Pathways Regulating Hippo Signaling
- Pathway:WP4541 - po-Merlin Signaling Dysregulation
- Pathway:WP4518 - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
- Pathway:WP4519 - Cerebral Organic Acidurias
- Pathway:WP4521 - Glycosylation and related congenital defects
- Pathway:WP4522 - Metabolic pathway of LDL, HDL and TG
- Pathway:WP4523 - Classical pathway of steroidogenesis, including diseases
- Pathway:WP4524 - The alternative pathway of fetal androgen synthesis
- Pathway:WP4549 - Fragile X Syndrome
- Pathway:WP4577 - WDR45 autophagy related pathway
- Pathway:WP4312 - Rett syndrome causing genes
- Pathway:WP3995 - Prion disease pathway
- Pathway:WP3853 - ERK Pathway in Huntington's Disease
- Pathway:WP4535 - Envelope proteins and their potential roles in EDMD physiopathology
- Pathway:WP2371 - Parkinsons Disease Pathway
- Pathway:WP2059 - Alzheimers Disease
- Pathway:WP4657 - 22q11.2 Deletion Syndrome
- Pathway:WP4656 - Joubert Syndrome
- Pathway:WP4746 - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
- Pathway:WP4673 - Genes involved in male infertility
- Pathway:WP4844 - The influence of laminopathies on Wnt signaling
- Pathway:WP4842 - Mammalian disorder of sexual development
- Pathway:WP4871 - Kisspeptin/Kisspeptin Receptor System in the Ovary
- Pathway:WP4838 - Regucalcin in proximal tubule epithelial kidney cells
- Pathway:WP4835 - Peroxiredoxin 2 induced ovarian failure
- Pathway:WP4830 - GDNF/RET signalling axis
- Pathway:WP4818 - Conversion of Angiotensinogen to Angiotensin II
- Pathway:WP4792 - Purine metabolism
- Pathway:WP4823 - Genes controlling renal nephrogenesis
- Pathway:WP4814 - Somatic Sex determination
- Pathway:WP4905 - 1q21.1 copy number variation syndrome
- Pathway:WP4906 - 3q29 copy number variation syndrome
- Pathway:WP4879 - Interacting Laminopathic Pathways
- Pathway:WP3998 - Prader-Willi and Angelman Syndrome
- Pathway:WP4545 - Oxysterols derived from cholesterol
